Samsara Therapeutics
  • About us
  • Our Science
    • The Lysoseeker Platform
    • Neurodegeneration
    • Rare Monogenic Disease
    • Our Pipeline
  • Insights
    • News
    • Blog
    • Publications
  • Careers
  • Contact
Select Page

Samsara Therapeutics Establishes Scientific Advisory Board

by Samsara@8529 | Jan 5, 2022 | Home, News

News Article Samsara Therapeutics Establishes Scientific Advisory Board   Michael Schlossmacher, Susan Perlman, Ed Tate and Christian Behl to help advance development of neurodegeneration and rare genetic disease therapeutics Oxford, UK and Boston, US, 06 January...

Categories

  • Blog (5)
  • Home (13)
  • News (8)

Recent Posts

  • Samsara Therapeutics adds eminent neurologist Professor Dame Pamela Shaw to its scientific advisory board to help accelerate ALS/MND treatment development
  • Samsara Therapeutics Parkinson’s drug receives funding boost from The Michael J. Fox Foundation
  • Samsara Therapeutics unveils promising autophagy drug candidate, offering new hope for people with Parkinson’s and motor neurone disease
  • Meet the Neuro Team – Modelling Neurodegeneration in a Dish
  • CMT Research Foundation and Samsara Therapeutics Partner on a Novel Therapeutic Approach for CMT1A

Archives

  • June 2023
  • May 2023
  • April 2023
  • November 2022
  • October 2022
  • September 2022
  • January 2022
  • December 2021
  • July 2021
  • June 2021
  • February 2021
  • December 2019

Categories

  • Blog
  • Home
  • News

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org
  • Twitter
  • Instagram

Designed by Elegant Themes | Powered by WordPress